Cancer Registry Software Market Worth $91 Million by 2024 - Exclusive Report by MarketsandMarkets™

Cancer Registry Software Market Worth $91 Million by 2024 - Exclusive Report by MarketsandMarkets™

PR Newswire

CHICAGO, March 22, 2019

CHICAGO, March 22, 2019 /PRNewswire/ -- According to the new market research report "Cancer Registry Software Market by Type (Standalone, Integration), Delivery (On-premise, Cloud), Database (Commercial, Public), Functionality (Cancer Reporting, Patient Care, Medical Research), End User, Region - Global Forecast to 2024", published by MarketsandMarkets™, the Cancer Patient Registry Software Market is projected to reach USD 91 million by 2024 from USD 56 million in 2019, at a CAGR of 10.4% during the forecast period. 

MarketsandMarkets Logo

Don't miss out on business opportunities in Cancer Registry Software Market

Growth in this market is driven by factors such as the increasing prevalence of cancer, favorable government initiatives, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and the growing use of cancer patient registry data for post-marketing surveillance.

Standalone software segment accounted for the largest share of the cancer patient registry software market, by type, in 2018

Based on type, the cancer patient registry software market is segmented into standalone and integrated software. The standalone software segment dominated this market in 2018 majorly due to the significant use of standalone software by government organizations and TPAs for population health management (due to its adaptability and interoperability). Also, standalone software customized for patient registries offers higher flexibility and features, such as multiple system usage and automatic upgradation. Due to these advantages, the use of standalone software is significantly high among end users.

Browse in-depth TOC on "Cancer Registry Software Market"

96 – Tables

29 – Figures  

124 – Pages  

Get 10% Free Customization on this Report: 

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=208177397

Cloud-based model segment to register higher growth in the cancer patient registry software market, by deployment model, during the forecast period

Based on deployment model, the cancer patient registry software market is segmented into on-premise and cloud-based models. During the forecast period, the cloud-based model segment is estimated to witness higher growth as it offers advantages such as cost-effectiveness, large storage capacity, flexibility, and regular automatic upgrades. The cloud-based model is highly cost-effective as it lowers hardware, software, and internal IT needs, which saves up-front and on-going IT expenses. Moreover, the storage capacity of data in a cloud-based model can be extended by paying additional charges to the vendor.

Inquiry Before Buying: 

https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=208177397

North America will continue to dominate the cancer patient registry software market during the forecast period

In 2018, North America was the largest regional market for cancer patient registry software, and this trend is expected to continue during the forecast period. This can be attributed to the high burden of cancer, government funding initiatives to encourage the development of cancer registries, high investments in healthcare IT, presence of major cancer registry software-developing players, and the high adoption rate of these solutions in the region.

The cancer patient registry software market is highly consolidated with a limited number of players. The prominent players operating in this market include Elekta (Sweden), Electronic Registry Systems, Inc. (US), Onco, Inc. (US), C/NET Solutions (US), Rocky Mountain Cancer Data Systems (US), and McKesson Corporation (US).

 Browse Adjacent Markets: Healthcare IT Market Research Reports & Consulting

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cancer-registry-software-market.asp
Visit Our Website: https://www.marketsandmarkets.com

https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg  

Voltar noticias em Inglês